IRP Schellenberg Research Prize

The IRP Schellenberg Research Prize recognises researchers whose outstanding scientific contributions and publications have advanced understanding of the development, injury and regeneration processes of the spinal cord.

Established in 2003, the Prize honours the memory of Ulrich Schellenberg, founder of the IFP Foundation in Zurich and co-founder of the IRP Foundation in Geneva, who died in 2001.

since 2003
up to
CHF 100,000
every 3 years
01

In Memory of Ulrich Schellenberg

The IRP Schellenberg Research Prize was created to perpetuate the memory and commitment of Ulrich Schellenberg and to support scientific excellence in the field of spinal cord research.

02

Purpose of the Prize

The Prize, worth up to CHF 100,000, recognises outstanding scientific work in the field of paraplegia.

Priority is given to young but already established and successful researchers conducting experimental work related to spinal cord development, injury, regeneration and functional recovery.

03

Use of Funds

The funds awarded may be used to recruit additional research staff and to purchase equipment or supplies.

The aim is to enable researchers to explore promising avenues that may contribute to progress in spinal cord regeneration, functional recovery and improved outcomes for people affected by spinal cord injury.

04

Evaluation and Award

Applications are evaluated by the IRP Scientific Committee.

Following this scientific evaluation, the recipient or recipients of the IRP Schellenberg Research Prize are selected by the IRP Foundation Board.

The funds are made available during the second half of the year in which the Prize is awarded.

The date of the next IRP Schellenberg Research Prize will be announced by IRP.

Research Prize booklet edited in 2020, which pays tribute to the 19 women and men researchers who have been recipients of the IRP Schellenberg Research Prize since it was founded in 2003.

IRP Schellenberg Research Prize

IRP Schellenberg Research Prize 2020

The 17th IRP Schellenberg Research Prize was awarded on 1 October 2020 at REHAB in Basel to Prof. Patrick Freund, Balgrist University Hospital in Zurich, and Prof. Jonas Frisén, Karolinska Institutet in Stockholm. The prize money of CHF 100,000 was awarded in equal shares to the two successful scientists.

Prof. Patrick Freund received his PhD in Biology from the University of Freiburg in 2008 and his degree in Medicine from the University of Zurich (UZH) in 2014. In 2018, he was awarded an SNSF Eccellenza Professorship in Paraplegiology at UZH. His research focuses on the multimodal assessment of functional and structural changes throughout the central nervous system caused by focal lesions of the spinal cord and brain. His interdisciplinary work focuses on the development and application of high-resolution imaging techniques as well as therapeutic studies. At the same time, he is completing advanced medical training to become a specialist in neurology. He is affiliated with the Wellcome Trust Centre for Neuroimaging and the Department of Brain Repair and Rehabilitation at the Queen Square University College London (UCL) Institute of Neurology, as well as the Department of Neurophysics at the Max Planck Institute in Leipzig.

Prof. Jonas Frisén received his MD and PhD from Karolinska Institutet in Stockholm, Sweden. After a period as a Postdoctoral Fellow in Princeton, USA, he returned to Sweden to establish his own research group, where he has been Tobias Foundation Professor of Stem Cell Research since 2001. He is a member of the Nobel Assembly and the Royal Swedish Academy of Sciences. Jonas Frisén identified neural stem cells in the adult spinal cord and demonstrated how they primarily contribute to scar formation. He also identified a small group of perivascular cells that form another major component of scar tissue and showed how reducing this process can promote axonal regeneration and some functional recovery following spinal cord injury in animal models. In addition, he developed a method for studying cell formation in the human nervous system by analysing the incorporation of an isotope originating from nuclear bomb tests conducted during the Cold War.